Phase I/II study of biweekly paclitaxel and radiation in androgen-ablated locally advanced prostate cancer Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Agents, Phytogenic
  • Paclitaxel
  • Prostatic Neoplasms

abstract

  • Concurrent biweekly paclitaxel with RT is feasible, with an MTD of 73.8 Gy. Recovery of gonadal function occurs in the majority of patients. These results encourage testing in a phase III setting.

publication date

  • September 15, 2008

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1200/JCO.2007.14.4105

PubMed ID

  • 18565883

Additional Document Info

start page

  • 2973

end page

  • 8

volume

  • 26

number

  • 18